• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Research & Development

Stanford uses CRISPR to correct sickle cell, human trials planned

November 8, 2016 By Sarah Faulkner

Stanford Medicine

Researchers from the Stanford University School of Medicine have reportedly used CRISPR, a gene-editing tool, to repair the gene that causes sickle cell disease. The team is planning the 1st human clinical trial using this technique to correct cells with sickle cell disease, according to Reuters.  “What we’ve finally shown is that we can do it. It’s […]

Filed Under: Clinical Trials, Featured, Research & Development, Stem Cells Tagged With: Broad Institute, Stanford University, University of California Berkeley

Researchers stunt growth of ovarian cancer with nanohydrogels

November 7, 2016 By Sarah Faulkner

Researchers stunt growth of ovarian cancer with nanohydrogels

Researchers at the Georgia Institute of Technology have developed a targeted therapy using nanohydrogels to stunt the growth of ovarian tumors in in vivo tests in mice, according to a new study. The nanohydrogel is a gel pellet that researchers can load with RNA to carry into cancer cells and knock down a particular protein. “The dramatic […]

Filed Under: Featured, Hydrogels, Nanoparticles, Oncology, Research & Development, Women's Health Tagged With: Georgia Institute of Technology

PAVmed partners with Boston institutions for antibiotic-eluting ear device

November 7, 2016 By Sarah Faulkner

Pavmed

PAVmed Inc. (NSDQ:PAVMU) said today that it inked an exclusive licensing agreement with academic institutions to develop and commercialize antibiotic-eluting resorbable ear tubes based on an aqueous silk technology designed by the institutions. The licensing deal includes agreements with Tufts University, Massachusetts Eye & Ear Infirmary and Massachusetts General Hospital, who developed the aqueous silk technology. As […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Research & Development, Respiratory Tagged With: Massachusetts Eye & Ear Infirmary, Massachusetts General Hospital, PAVmed, Tufts University

SanBio touts 1-year data on stem cell transplant for stroke

November 4, 2016 By Sarah Faulkner

SanBio touts 1-year data on stem cell transplant for stroke

SanBio Inc. (TYO:4592) released 1-year interim data from the phase 1/2a, open-label, single-arm dose escalation study of its intracerebral stem cell implant designed for stroke patients. The Mountain View, Calif.-based company touted the results, which indicated that itsSB623 stem cell treatment was generally safe, well-tolerated and associated with improved motor functions in patients  suffering with chronic impairment following […]

Filed Under: Clinical Trials, Featured, Neurological, Research & Development, Stem Cells Tagged With: SanBio Inc

Lab models drug-eluting polymer beads in blood flow

November 4, 2016 By Sarah Faulkner

Researchers from the University of Huddersfield developed a method to predict how drug-eluting polymer beads can affect the body if they are modified. The UK team of researchers published their work in the European Journal of Pharmaceutical Sciences. Polymer beads are frequently used in cases of liver cancer, where they’re injected into a patient’s arteries to block […]

Filed Under: Drug-Device Combinations, Featured, Oncology, Research & Development Tagged With: University of Huddersfield

Encapsulating single cells in tunable hydrogel could boost cell therapies

November 3, 2016 By Sarah Faulkner

Encapsulating single cells in tunable hydrogel could boost cell therapies

Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A. Paulson School of Engineering and Applied Sciences have developed a microfluidic approach to trap individual cells within a hydrogel material that can be tuned to match the physiological conditions of the body, according to a study published this […]

Filed Under: Hydrogels, Research & Development Tagged With: Harvard University, Wyss Institute

Droplet ‘taxicabs’ transport nanoparticles into cell

November 2, 2016 By Sarah Faulkner

Researchers from the University of Massachusetts-Amherst have developed polymer-stabilized droplet carriers that can identify and engulf nanoparticles to bring them into a cell. The team was inspired by proteins that can recognize microbes or debris and then encapsulate the material to get rid of it. The team believes that this demonstration of surface-to-surface nanoparticle transport, […]

Filed Under: Featured, Nanoparticles, Research & Development Tagged With: University of Massachusetts Amherst

Polymeric nanoparticles transport quantum dots into cells

November 1, 2016 By Sarah Faulkner

Researchers from the University of Tokyo treated the surfaces of nanoparticles with polymers and enabled the transport of quantum dots into cells, according to a study published in Science and Technology of Advanced Materials. By coating nanoparticles with MPC polymers, researchers can make substances that are easily transported and delivered into the blood or other tissue because […]

Filed Under: Featured, Nanoparticles, Research & Development Tagged With: University of Tokyo

PharmaJet, Vaccibody collaborate on needle-free HPV vaccine

October 25, 2016 By Sarah Faulkner

Vaccibody, PharmaJet

PharmaJet and Vaccibody inked a collaborative deal to provide needle-free injection tech for the development of a human papillomavirus vaccine. HPV is the cause of virtually all cervical cancer, according to the National Cancer Institute, and just 2 types of HPV, 16 and 18, are responsible for about 70% of all cases. PharmaJet’s device is […]

Filed Under: Drug-Device Combinations, Featured, Research & Development Tagged With: PharmaJet, Vaccibody

Researchers boost stem cell programming with gene mutation

October 25, 2016 By Sarah Faulkner

Researchers discovered a way to increase the efficiency of stem cell programming using research on a rare genetic disease, according to a study published in the Proceedings of the National Academy of Sciences.  Induced pluripotent stem cells are created from skin cells and can be transformed into any type of cell in the body. Using existing […]

Filed Under: Featured, Research & Development, Stem Cells

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 41
  • Page 42
  • Page 43
  • Page 44
  • Page 45
  • Interim pages omitted …
  • Page 48
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS